Nyxoah Sa (NYXH)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Nyxoah Sa Stock (NYXH) Company Profile

Healthcare (1110)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

NYXH's Discussions on Twitter

Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
NYXH Nyxoah Sa	4.88	193.19M	4.71M	-46.77M	-60.34M	-1.6792
ISRG Intuitive Surgical Inc	500.76	175.20B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	182.68	50.46B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	82.29	39.65B	10.19B	1.05B	1.38B	2.1044
MDLN Medline Inc	47.71	38.41B	27.43B	1.27B	1.01B	1.5829
RMD Resmed Inc	258.91	37.27B	5.40B	1.49B	1.78B	10.12

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-07-31	Eingeleitet	H.C. Wainwright	Buy
2023-07-19	Eingeleitet	Robert W. Baird	Neutral
2022-04-21	Eingeleitet	Oppenheimer	Outperform
2022-04-06	Eingeleitet	Wolfe Research	Peer Perform
2021-12-21	Fortgesetzt	Cantor Fitzgerald	Overweight
2021-07-28	Eingeleitet	Cantor Fitzgerald	Overweight

Alle ansehen

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Nyxoah Sa (NYXH)

Nyxoah Sa Stock (NYXH) Company Profile

Compare NYXH vs ISRG, BDX, ALC, MDLN, RMD

Nyxoah Sa Stock (NYXH) Upgrades & Downgrades

Nyxoah Sa Aktie (NYXH) Neueste Nachrichten

Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East - Bitget

Nyxoah Announces the Signature of a Memorandum of - GlobeNewswire

Nyxoah SA (NASDAQ:NYXH) Short Interest Up 29.0% in January - Defense World

(NYXH) Volatility Zones as Tactical Triggers - Stock Traders Daily

Contrasting Hinge Health (NYSE:HNGE) and Nyxoah (NASDAQ:NYXH) - Defense World

Is Nyxoah SA stock undervalued right nowJuly 2025 Highlights & Weekly Stock Breakout Alerts - mfd.ru

Nyxoah SA (NYXH) Stock Analysis: A Healthcare Innovator with a Promising 138.98% Upside Potential - DirectorsTalk Interviews

Returns Recap: Will Nyxoah SA benefit from AI trendsWeekly Stock Recap & Community Supported Trade Ideas - baoquankhu1.vn

Is Nyxoah SA stock overvalued or fairly pricedJuly 2025 Update & Fast Gain Swing Trade Alerts - mfd.ru

Can Nyxoah SA expand into new marketsTrade Analysis Summary & Daily Profit Maximizing Trade Tips - mfd.ru

What is the long term forecast for Nyxoah SA stockJuly 2025 Sector Moves & High Accuracy Trade Signal Alerts - mfd.ru

Nyxoah's Revenue On The Rise- Will The Stock Wake From Its Slumber? - RTTNews

Guidance Update: Is now the right time to enter Nyxoah SABond Market & Daily Stock Trend Watchlist - baoquankhu1.vn

Price-Driven Insight from (NYXH) for Rule-Based Strategy - Stock Traders Daily

Nyxoah SA (NYXH) Stock Analysis: A 137% Potential Upside In The Healthcare Sector - DirectorsTalk Interviews

Aug PreEarnings: Can Nyxoah SA sustain its profitabilityBear Alert & Expert Approved Trade Ideas - baoquankhu1.vn

Price Action: Should I hold or sell Nyxoah SA now2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn

Ideas Watch: Is now the right time to enter Nyxoah SAQuarterly Trade Summary & High Accuracy Investment Entry Signals - baoquankhu1.vn

Will Nyxoah SA benefit from rising consumer demandWeekly Stock Report & Smart Money Movement Tracker - baoquankhu1.vn

Nyxoah (NASDAQ:NYXH) Shares Down 0.4% – Time to Sell? - Defense World

Nyxoah (NASDAQ:NYXH) Shares Down 0.4%Time to Sell? - MarketBeat

Nyxoah Expands Belgian Manufacturing Hub to Support Global Growth in OSA Therapy - The Globe and Mail

Risk Hedge: Is Nyxoah SA stock a good dividend stockTrade Ideas & Long-Term Growth Plans - mfd.ru

Can Nyxoah SA sustain its profitabilityJuly 2025 Big Picture & AI Powered Buy and Sell Recommendations - mfd.ru

Volume Report: Can Nyxoah SA ride the EV waveQuarterly Portfolio Review & Weekly High Return Forecasts - baoquankhu1.vn

Nyxoah Expands Belgian Manufacturing Capacity to Support Global Growth - Sleep Review

Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews

Nyxoah invests in further expanding its Belgian manufacturing capacity to support its worldwide growth - marketscreener.com

Nyxoah says co invests expanding its Belgian manufacturing capacity - marketscreener.com

Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth - GlobeNewswire

Does Nyxoah SA have pricing power2025 Risk Factors & Growth Focused Stock Reports - bollywoodhelpline.com

Aug Sectors: Is Flanigans Enterprises Inc stock a falling knife or bargain buy2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn

(NYXH) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

NYXH: Rapid U.S. launch and strong clinical results position Genio for significant market growth - TradingView

NYXH: Genio's innovative sleep apnea device drives rapid U.S. adoption and strong early sales - TradingView — Track All Markets

Oppenheimer Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $13 - 富途牛牛

Nyxoah’s First Full U.S. Sales Quarter Fuels Triple-Digit Revenue Growth in 2025 - The Globe and Mail

Nyxoah (NASDAQ: NYXH) reports preliminary 2025 results and Q1 2026 view - Stock Titan

Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target By Investing.com - Investing.com South Africa

Stifel Maintains Nyxoah SA(NYXH.US) With Buy Rating, Maintains Target Price $12 - 富途资讯

Stifel reiterates Buy rating on Nyxoah stock, maintains $12 price target - Investing.com Australia

Is Nyxoah SA stock a safe investment in uncertain markets2025 Growth vs Value & Verified Swing Trading Watchlist - Bộ Nội Vụ

Belgium-based Nyxoah’s net revenue expected to increase 348% in Q4 2025 - Medical Buyer

Nyxoah Shares Surge On Strong Q4 Preliminary Revenue - Nasdaq

Nyxoah Announces Preliminary Results for the Fourth Quarter and Full Year 2025 and Provides Revenue Guidance for the First Quarter of 2026 - The Manila Times

News - FinancialContent

Publication relating to transparency notification - GlobeNewswire

Nyxoah SA's (EBR:NYXH) market cap rose €19m last week; retail investors who hold 44% profited and so did insiders - simplywall.st

Aug Opening: Is Nyxoah SA stock a contrarian buyJuly 2025 Price Swings & AI Forecasted Entry/Exit Points - Bộ Nội Vụ

Is Nyxoah SA stock a good choice for value investorsSeasonal Picks & what to check before ordering - Улправда

Is Nyxoah SA stock a contrarian buyMarket Risk Summary & Free Fast Gain Swing Trade Alerts - Улправда

Finanzdaten der Nyxoah Sa-Aktie (NYXH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie NYXH